Zolantidine
Chemical compound
- None
- N-[3-[3-(piperidin-1-ylmethyl)phenoxy]propyl]-1,3-benzothiazol-2-amine
- 104076-38-2
- 91769
- 82866
- M1108XAY01
- ChEMBL419296
- DTXSID6048460
- Interactive image
- n1c4ccccc4sc1NCCCOc2cc(ccc2)CN3CCCCC3
InChI
- InChI=1S/C22H27N3OS/c1-4-13-25(14-5-1)17-18-8-6-9-19(16-18)26-15-7-12-23-22-24-20-10-2-3-11-21(20)27-22/h2-3,6,8-11,16H,1,4-5,7,12-15,17H2,(H,23,24)
- Key:KUBONGDXTUOOLM-UHFFFAOYSA-N
Zolantidine is a brain-penetrating selective histamine H2 receptor (HRH2) antagonist developed by Smith, Kline & French, with the research code of SK&F 95282. It is a benzothiazole derivative with a 30-fold higher potency for H2 receptors than other peripheral and central receptors.[1]
References
- ^ Calcutt CR, Ganellin CR, Griffiths R, Leigh BK, Maguire JP, Mitchell RC, et al. (January 1988). "Zolantidine (SK&F 95282) is a potent selective brain-penetrating histamine H2-receptor antagonist". British Journal of Pharmacology. 93 (1): 69–78. doi:10.1111/j.1476-5381.1988.tb11406.x. PMC 1853786. PMID 2894879.
- v
- t
- e
Histamine receptor modulators
| Agonists | |
|---|---|
| Antagonists |
|
| Agonists | |
|---|---|
| Antagonists |
|
| Agonists |
|
|---|---|
| Antagonists |
|
- See also
- Receptor/signaling modulators
- Monoamine metabolism modulators
- Monoamine reuptake inhibitors
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
